Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-004143
Filing Date
2025-01-10
Accepted
2025-01-10 16:05:53
Documents
5
Effectiveness Date
2025-01-10

Document Format Files

Seq Description Document Type Size
1 S-8 jan_10_2025_s-8.htm S-8 231231
2 EX-5.1 achv-ex5_1.htm EX-5.1 14672
3 EX-23.2 achv-ex23_2.htm EX-23.2 3693
4 EX-FILING FEES achv-exfiling_fees.htm EX-FILING FEES 29750
5 GRAPHIC img223336490_0.jpg GRAPHIC 17174
  Complete submission text file 0000950170-25-004143.txt   304418
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-284208 | Film No.: 25522898
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)